Clinical Trials Logo

Uterine Cervical Neoplasms clinical trials

View clinical trials related to Uterine Cervical Neoplasms.

Filter by:

NCT ID: NCT04022148 Not yet recruiting - Cancer of Cervix Clinical Trials

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Start date: August 1, 2019
Phase:
Study type: Observational [Patient Registry]

A nonrandomized, non-double blinded prospective cohort study to evaluate the preventive efficacy of quadrivalent HPV6/11/16/18 vaccine for the persistent infection of HPV16 genotype or HPV18 genotype in Japanese women aged 27-45 years.

NCT ID: NCT04000477 Not yet recruiting - Cervical Cancer Clinical Trials

Comparison of 2 Types of Cervical Specimens in Patients With a Pathological Screening Smear

ENDOCOL
Start date: March 2021
Phase: N/A
Study type: Interventional

The recommendations on the method and the realization of the cervico-uterine smears are clear. With regard to performing endocervical curettage, several methods are possible without precise consensus. In general, the Kevorkian curette is widely used. However, it is often reported by doctors and patients that curettage is painful. Some articles show that the cytobrush would be less painful. While keeping a percentage of correct curettage failures, it is sought to show that the cytobrush would improve the comfort of the patient during curettage.

NCT ID: NCT03971032 Not yet recruiting - Uterine Neoplasms Clinical Trials

An In-vitro Real-time System Based on Tissue Smears to Identify Malignancy During Hysteroscopic Procedure

Start date: December 31, 2019
Phase: N/A
Study type: Interventional

The aim of the current study is to develop a near real-time system using infrared spectroscopy, that will evaluate the histological specimen that was removed from the uterine cavity during the hysteroscopy.

NCT ID: NCT03961412 Not yet recruiting - Cervical Cancer Clinical Trials

A Family-based Intervention to Improve Pap Test Screening Among Under-screened Chinese American Immigrant Women

Start date: July 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of this study is to find out the impact of the involvement of an influential person(s) (e.g., spouse, partners, parents, children, friends) on Pap test screening intention and behaviors, Pap test self-efficacy, and perceived benefits and barriers to Pap test screening among Chinese American immigrant women. These data specific to the impact of the involvement of an influential person on Pap test screening could be used to develop successful cancer prevention programs that target the specific needs of Chinese populations.

NCT ID: NCT03885505 Not yet recruiting - Quality of Life Clinical Trials

An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients

Start date: June 25, 2019
Phase:
Study type: Observational

Cervical cancer radiotherapy patients have a decline in quality of life and sexual quality of life

NCT ID: NCT03813576 Not yet recruiting - Cervical Cancer Clinical Trials

Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study

Start date: March 2019
Phase: N/A
Study type: Interventional

In Singapore, the current cervical cancer screening uptake among women in Singapore has remained at low 50% since its introduction in 2004. It has been widely reported that under-screened women have the highest risk of cervical cancer. Self-sampling HPV DNA screening may be a solution to the low uptake rates of local women, particularly among the under-screened population in Singapore. Self-sampling comprises women using a swab to obtain samples from their vagina. In this study, we are comparing the sensitivity of detecting HPV positive women using HPV DNA test with self-sampling using flocked swab with the current physician sampling method. We also aim to determine acceptability of self-sampling HPV DNA test using flocked swab in cervical cancer screening. Designed as a feasibility study, it will comprise a prospective study of 300 women attending clinics in National University Hospital (NUH) and National Cancer Institute Singapore (NCIS).

NCT ID: NCT03750214 Not yet recruiting - Clinical trials for Cervical Cancer Screening

Evaluation of the Biop Colposcopy System's Safety and Performance (Accuracy of Its Registration Procedure)

Start date: May 2020
Phase: N/A
Study type: Interventional

This is a multi-center, prospective, non-randomized, confirmatory study to evaluate the safety and performance of the Biop Digital Colposcope and the accuracy of the image registration procedure between the Biop Digital Colposcope unit and the Biop Micro Colposcope probe unit.

NCT ID: NCT03721484 Not yet recruiting - Cervical Cancer Clinical Trials

CINtec PLUS Triage in HPV Primary Screening

Start date: January 2019
Phase: N/A
Study type: Interventional

Prospective study which will recruit participants when they attend for a routine cervical screening. The study will evaluate the use of CINtec PLUS for triage of human papillomavirus (HPV) positive participants in HPV primary screening.

NCT ID: NCT03659110 Not yet recruiting - Cervical Cancer Clinical Trials

Post-Approval Safety Monitoring Program to Assess the Safety Profile of GARDASIL in China Usual Practice

Start date: October 1, 2018
Phase:
Study type: Observational

This is a post-Approval Safety Monitoring Program to assess the safety profile of GARDASIL in china usual practice.

NCT ID: NCT03655977 Not yet recruiting - Cervical Cancer Clinical Trials

Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer

RaPiCCa
Start date: September 1, 2018
Phase: N/A
Study type: Interventional

The main goal of this project is to evaluate the potential and feasibility of hybrid PET/MRI functional imaging to non-invasively measure tumor characteristics for radiation therapy planning (RT) for cervical cancer. It will be assessed how the complementary information of tumor characteristics can contributed to better understanding of tumor delineation. Another endpoint of this study is to evaluate a new PET-tracer (68Ga-NODAGA- E[c(RGDyK)]2) enabling imaging of tumor-angiogenesis.